Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta.

OBJECTIVE Although increased use of intrapartum antibiotics caused significant declines in early-onset group B Streptococcus (GBS) infection, the effect on infections caused by other pathogens is not clear. The objective of this study was to determine trends in the incidence of early-onset sepsis caused by organisms other than group B streptococcus in the era of antimicrobial prophylaxis. METHODS We conducted surveillance for early-onset sepsis as part of the Active Bacterial Core surveillance. A case was defined as isolation of bacteria from blood or cerebrospinal fluid from an infant who was 0 to 6 days of age and born in the surveillance area during 1998 through 2000 (248 184 births). RESULTS We identified 408 cases of early-onset infection. GBS caused 166 (40.7%) cases (52 in 1998, 51 in 1999, and 63 in 2000 for incidences 0.62, 0.62, and 0.76 cases per 1000 live births, respectively). Other bacterial pathogens were identified in 242 cases (82 in 1998, 79 in 1999, and 81 in 2000 for incidences 0.99, 0.95, and 0.98 per 1000 live births, respectively) of early-onset sepsis. Escherichia coli caused 70 cases (0.25, 0.28, and 0.31 cases per 1000 live births, respectively, in 1998-2000). The proportion of E coli infections that were resistant to ampicillin increased significantly among preterm infants from 29% (2 of 7) in 1998 to 84% (16 of 18) in 2000 but not in full-term infants: 50% (4 of 8) in 1998 and 25% (1 of 4) in 2000. CONCLUSIONS Whereas rates of early-onset sepsis caused by GBS and other pathogens were low and did not change significantly during the study period, antibiotic-resistant E coli infections among preterm infants increased. Overall, these trends are reassuring, but careful evaluation of the increase in resistant infections in very young infants is critical in the future.

[1]  M. Pearlman Prevention of early-onset group B streptococcal disease in newborns. , 2003, Obstetrics and gynecology.

[2]  K. O'Brien,et al.  Early-onset neonatal sepsis in the era of group B streptococcal prevention. , 2001, Pediatrics.

[3]  T. Hooton,et al.  Increasing Antimicrobial Resistance and the Management of Uncomplicated Community-Acquired Urinary Tract Infections , 2001, Annals of Internal Medicine.

[4]  S. Kenyon,et al.  Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial , 2001, The Lancet.

[5]  W. Tarnow-Mordi,et al.  Broad-spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial , 2001, The Lancet.

[6]  A. Schuchat,et al.  Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization. , 2001, American journal of obstetrics and gynecology.

[7]  J. Karlowsky,et al.  Antimicrobial Resistance Among Escherichia coli Urinary Tract Isolates in the United States: A Current View Provided by Electronic Surveillance , 2001 .

[8]  A. Schuchat,et al.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. , 2000, The New England journal of medicine.

[9]  B. Stoll,et al.  Risk Factors and Opportunities for Prevention of Early-Onset Neonatal Sepsis: A Multicenter Case-Control Study , 1999, Pediatrics.

[10]  T. Asrat,et al.  Incidence of intrapartum maternal risk factors for identifying neonates at risk for early-onset group B streptococcal sepsis: A prospective study. , 1999, American journal of obstetrics and gynecology.

[11]  B. Sibai,et al.  Antibiotic use in pregnancy and drug-resistant infant sepsis. , 1999, American journal of obstetrics and gynecology.

[12]  P. Bornick,et al.  Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. , 1999, American journal of obstetrics and gynecology.

[13]  D. McClish,et al.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  D. Isaacs,et al.  Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections. , 1999, The Pediatric infectious disease journal.

[15]  G. Escobar,et al.  Preventing Neonatal Group B Streptococcal Disease: Cost-Effectiveness in a Health Maintenance Organization and the Impact of Delayed Hospital Discharge for Newborns Who Received Intrapartum Antibiotics , 1999, Pediatrics.

[16]  D. Scholes,et al.  Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. , 1999, JAMA.

[17]  T. Asrat,et al.  Potential consequences of widespread antepartal use of ampicillin. , 1998, American journal of obstetrics and gynecology.

[18]  R. Black,et al.  Zinc Supplementation Reduces the Incidence of Acute Lower Respiratory Infections in Infants and Preschool Children: A Double-blind, Controlled Trial , 1998, Pediatrics.

[19]  L. Wright,et al.  Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. , 1997, Pediatrics.

[20]  J. Tyson,et al.  Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. , 1996, The Journal of pediatrics.

[21]  G. Cutter,et al.  Strategies for the Prevention of Early‐Onset Neonatal Group B Streptococcal Sepsis: A Decision Analysis , 1994, Obstetrics and gynecology.

[22]  R. Ehrenkranz,et al.  A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. , 1990, The Pediatric infectious disease journal.

[23]  K. Boyer,et al.  Prevention of early‐onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis , 1986, The New England journal of medicine.

[24]  R. Ehrenkranz,et al.  A half century of neonatal sepsis at Yale: 1928 to 1978. , 1981 .